Whitworth Kristin M, Li Rongfeng, Spate Lee D, Wax David M, Rieke August, Whyte Jeffrey J, Manandhar Gaurishankar, Sutovsky Miriam, Green Jonathan A, Sutovsky Peter, Prather Randall S
Division of Animal Sciences, University of Missouri, Columbia, Missouri 65211, USA.
Mol Reprod Dev. 2009 May;76(5):490-500. doi: 10.1002/mrd.20987.
The following experiments compared the efficiency of three fusion/activation protocols following somatic cell nuclear transfer (SCNT) with porcine somatic cells transfected with enhanced green fluorescent protein driven by the chicken beta-actin/rabbit beta-globin hybrid promoter (pCAGG-EGFP). The three protocols included electrical fusion/activation (NT1), electrical fusion/activation followed by treatment with a reversible proteasomal inhibitor MG132 (NT2) and electrical fusion in low Ca(2+) followed by chemical activation with thimerosal/dithiothreitol (NT3). Data were collected at Days 6, 12, 14, 30, and 114 of gestation. Fusion rates, blastocyst-stage mean cell numbers, recovery rates, and pregnancy rates were calculated and compared between protocols. Fusion rates were significantly higher for NT1 and NT2 compared to NT3 (P < 0.05). There was no significant difference in mean nuclear number. Pregnancy rate for NT2 was 100% (n = 19) at all stages collected and was significantly higher than NT1 (71.4%, n = 28; P < 0.05), but was not significantly higher than NT3 (82.6%, n = 23; P < 0.15). Recovery rates were calculated based on the number of embryos, conceptuses, fetuses, or piglets present at the time of collection, divided by the number of embryos transferred to the recipient gilts. Recovery rates between the three groups were not significantly different at any of the stages collected (P > 0.05). All fusion/activation treatments produced live, pCAGG-EGFP positive piglets from SCNT. Treatment with MG132 after fusion/activation of reconstructed porcine embryos was the most effective method when comparing the overall pregnancy rates. The beneficial effect of NT2 protocol may be due to the stimulation of proteasomes that infiltrate donor cell nucleus shortly after nuclear transfer.
以下实验比较了三种融合/激活方案在体细胞核移植(SCNT)后的效率,该体细胞核移植使用的猪体细胞转染了由鸡β-肌动蛋白/兔β-珠蛋白杂交启动子(pCAGG-EGFP)驱动的增强型绿色荧光蛋白。这三种方案包括电融合/激活(NT1)、电融合/激活后用可逆蛋白酶体抑制剂MG132处理(NT2)以及在低钙(2+)条件下进行电融合,随后用硫柳汞/二硫苏糖醇进行化学激活(NT3)。在妊娠第6、12、14、30和114天收集数据。计算并比较了各方案之间的融合率、囊胚期平均细胞数、回收率和妊娠率。与NT3相比,NT1和NT2的融合率显著更高(P < 0.05)。平均核数无显著差异。在所有收集阶段,NT2的妊娠率为100%(n = 19),显著高于NT1(71.4%,n = 28;P < 0.05),但不显著高于NT3(82.6%,n = 23;P < 0.15)。回收率根据收集时存在的胚胎、概念胎、胎儿或仔猪数量计算,除以移植到受体后备母猪的胚胎数量。在任何收集阶段,三组之间的回收率均无显著差异(P > 0.05)。所有融合/激活处理均从体细胞核移植产生了活的、pCAGG-EGFP阳性仔猪。比较总体妊娠率时,融合/激活后用MG132处理重建猪胚胎是最有效的方法。NT2方案的有益效果可能是由于蛋白酶体在核移植后不久渗透到供体细胞核中所产生的刺激作用。